Dec 13, 2000
Genmab Initiates Phase II Study With HuMax-CD4

Dec 6, 2000
Gemini Genomics and Genmab Announce Collaboration to Develop Human Antibody Therapeutics

Nov 29, 2000
Genmab Announces Finacial Results for the First Nine Months of 2000

Nov 1, 2000
Genmab Announces Positive Phase I/II Results for HuMax-CD4 to Treat Rheumatoid Arthritis

Jun 13, 2000
Genmab Completes $40.5 Million Financing

Apr 11, 2000
Genmab Raises Additional $4.8 Million and Adds New Product